Global Frovatriptan Market Growth 2023-2029

February 2023 | 103 pages | ID: G5599B66A1D7EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Frovatriptan is a triptan drug developed by Vernalis for the treatment of migraine headaches, in particular those associated with menstruation. Frovatriptan causes vasoconstriction of arteries and veins that supply blood to the head

LPI (LP Information)' newest research report, the “Frovatriptan Industry Forecast” looks at past sales and reviews total world Frovatriptan sales in 2022, providing a comprehensive analysis by region and market sector of projected Frovatriptan sales for 2023 through 2029. With Frovatriptan sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Frovatriptan industry.

This Insight Report provides a comprehensive analysis of the global Frovatriptan landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Frovatriptan portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Frovatriptan market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Frovatriptan and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Frovatriptan.

The global Frovatriptan market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Frovatriptan is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Frovatriptan is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Frovatriptan is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Frovatriptan players cover Ligand Pharmaceuticals, Endo Pharmaceuticals, Doc Generici, Menarini, Novartis, Almac, Glenmark Generics, Teva and Zambon, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Frovatriptan market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• Hospital
• Drug Store

Segmentation by application

• Menstrual Migraines
• Migraine with Aura
• Migraine without Aura

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Ligand Pharmaceuticals
• Endo Pharmaceuticals
• Doc Generici
• Menarini
• Novartis
• Almac
• Glenmark Generics
• Teva
• Zambon
• Apotex
• G.L. Pharma
• Chanelle Pharma

Key Questions Addressed in this Report

What is the 10-year outlook for the global Frovatriptan market?

What factors are driving Frovatriptan market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Frovatriptan market opportunities vary by end market size?

How does Frovatriptan break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Frovatriptan Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Frovatriptan by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Frovatriptan by Country/Region, 2018, 2022 & 2029
2.2 Frovatriptan Segment by Type
  2.2.1 Hospital
  2.2.2 Drug Store
2.3 Frovatriptan Sales by Type
  2.3.1 Global Frovatriptan Sales Market Share by Type (2018-2023)
  2.3.2 Global Frovatriptan Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Frovatriptan Sale Price by Type (2018-2023)
2.4 Frovatriptan Segment by Application
  2.4.1 Menstrual Migraines
  2.4.2 Migraine with Aura
  2.4.3 Migraine without Aura
2.5 Frovatriptan Sales by Application
  2.5.1 Global Frovatriptan Sale Market Share by Application (2018-2023)
  2.5.2 Global Frovatriptan Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Frovatriptan Sale Price by Application (2018-2023)

3 GLOBAL FROVATRIPTAN BY COMPANY

3.1 Global Frovatriptan Breakdown Data by Company
  3.1.1 Global Frovatriptan Annual Sales by Company (2018-2023)
  3.1.2 Global Frovatriptan Sales Market Share by Company (2018-2023)
3.2 Global Frovatriptan Annual Revenue by Company (2018-2023)
  3.2.1 Global Frovatriptan Revenue by Company (2018-2023)
  3.2.2 Global Frovatriptan Revenue Market Share by Company (2018-2023)
3.3 Global Frovatriptan Sale Price by Company
3.4 Key Manufacturers Frovatriptan Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Frovatriptan Product Location Distribution
  3.4.2 Players Frovatriptan Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR FROVATRIPTAN BY GEOGRAPHIC REGION

4.1 World Historic Frovatriptan Market Size by Geographic Region (2018-2023)
  4.1.1 Global Frovatriptan Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Frovatriptan Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Frovatriptan Market Size by Country/Region (2018-2023)
  4.2.1 Global Frovatriptan Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Frovatriptan Annual Revenue by Country/Region (2018-2023)
4.3 Americas Frovatriptan Sales Growth
4.4 APAC Frovatriptan Sales Growth
4.5 Europe Frovatriptan Sales Growth
4.6 Middle East & Africa Frovatriptan Sales Growth

5 AMERICAS

5.1 Americas Frovatriptan Sales by Country
  5.1.1 Americas Frovatriptan Sales by Country (2018-2023)
  5.1.2 Americas Frovatriptan Revenue by Country (2018-2023)
5.2 Americas Frovatriptan Sales by Type
5.3 Americas Frovatriptan Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Frovatriptan Sales by Region
  6.1.1 APAC Frovatriptan Sales by Region (2018-2023)
  6.1.2 APAC Frovatriptan Revenue by Region (2018-2023)
6.2 APAC Frovatriptan Sales by Type
6.3 APAC Frovatriptan Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Frovatriptan by Country
  7.1.1 Europe Frovatriptan Sales by Country (2018-2023)
  7.1.2 Europe Frovatriptan Revenue by Country (2018-2023)
7.2 Europe Frovatriptan Sales by Type
7.3 Europe Frovatriptan Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Frovatriptan by Country
  8.1.1 Middle East & Africa Frovatriptan Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Frovatriptan Revenue by Country (2018-2023)
8.2 Middle East & Africa Frovatriptan Sales by Type
8.3 Middle East & Africa Frovatriptan Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Frovatriptan
10.3 Manufacturing Process Analysis of Frovatriptan
10.4 Industry Chain Structure of Frovatriptan

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Frovatriptan Distributors
11.3 Frovatriptan Customer

12 WORLD FORECAST REVIEW FOR FROVATRIPTAN BY GEOGRAPHIC REGION

12.1 Global Frovatriptan Market Size Forecast by Region
  12.1.1 Global Frovatriptan Forecast by Region (2024-2029)
  12.1.2 Global Frovatriptan Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Frovatriptan Forecast by Type
12.7 Global Frovatriptan Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Ligand Pharmaceuticals
  13.1.1 Ligand Pharmaceuticals Company Information
  13.1.2 Ligand Pharmaceuticals Frovatriptan Product Portfolios and Specifications
  13.1.3 Ligand Pharmaceuticals Frovatriptan Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Ligand Pharmaceuticals Main Business Overview
  13.1.5 Ligand Pharmaceuticals Latest Developments
13.2 Endo Pharmaceuticals
  13.2.1 Endo Pharmaceuticals Company Information
  13.2.2 Endo Pharmaceuticals Frovatriptan Product Portfolios and Specifications
  13.2.3 Endo Pharmaceuticals Frovatriptan Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Endo Pharmaceuticals Main Business Overview
  13.2.5 Endo Pharmaceuticals Latest Developments
13.3 Doc Generici
  13.3.1 Doc Generici Company Information
  13.3.2 Doc Generici Frovatriptan Product Portfolios and Specifications
  13.3.3 Doc Generici Frovatriptan Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Doc Generici Main Business Overview
  13.3.5 Doc Generici Latest Developments
13.4 Menarini
  13.4.1 Menarini Company Information
  13.4.2 Menarini Frovatriptan Product Portfolios and Specifications
  13.4.3 Menarini Frovatriptan Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Menarini Main Business Overview
  13.4.5 Menarini Latest Developments
13.5 Novartis
  13.5.1 Novartis Company Information
  13.5.2 Novartis Frovatriptan Product Portfolios and Specifications
  13.5.3 Novartis Frovatriptan Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Novartis Main Business Overview
  13.5.5 Novartis Latest Developments
13.6 Almac
  13.6.1 Almac Company Information
  13.6.2 Almac Frovatriptan Product Portfolios and Specifications
  13.6.3 Almac Frovatriptan Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Almac Main Business Overview
  13.6.5 Almac Latest Developments
13.7 Glenmark Generics
  13.7.1 Glenmark Generics Company Information
  13.7.2 Glenmark Generics Frovatriptan Product Portfolios and Specifications
  13.7.3 Glenmark Generics Frovatriptan Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Glenmark Generics Main Business Overview
  13.7.5 Glenmark Generics Latest Developments
13.8 Teva
  13.8.1 Teva Company Information
  13.8.2 Teva Frovatriptan Product Portfolios and Specifications
  13.8.3 Teva Frovatriptan Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Teva Main Business Overview
  13.8.5 Teva Latest Developments
13.9 Zambon
  13.9.1 Zambon Company Information
  13.9.2 Zambon Frovatriptan Product Portfolios and Specifications
  13.9.3 Zambon Frovatriptan Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 Zambon Main Business Overview
  13.9.5 Zambon Latest Developments
13.10 Apotex
  13.10.1 Apotex Company Information
  13.10.2 Apotex Frovatriptan Product Portfolios and Specifications
  13.10.3 Apotex Frovatriptan Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 Apotex Main Business Overview
  13.10.5 Apotex Latest Developments
13.11 G.L. Pharma
  13.11.1 G.L. Pharma Company Information
  13.11.2 G.L. Pharma Frovatriptan Product Portfolios and Specifications
  13.11.3 G.L. Pharma Frovatriptan Sales, Revenue, Price and Gross Margin (2018-2023)
  13.11.4 G.L. Pharma Main Business Overview
  13.11.5 G.L. Pharma Latest Developments
13.12 Chanelle Pharma
  13.12.1 Chanelle Pharma Company Information
  13.12.2 Chanelle Pharma Frovatriptan Product Portfolios and Specifications
  13.12.3 Chanelle Pharma Frovatriptan Sales, Revenue, Price and Gross Margin (2018-2023)
  13.12.4 Chanelle Pharma Main Business Overview
  13.12.5 Chanelle Pharma Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Frovatriptan Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Frovatriptan Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Hospital
Table 4. Major Players of Drug Store
Table 5. Global Frovatriptan Sales by Type (2018-2023) & (K Units)
Table 6. Global Frovatriptan Sales Market Share by Type (2018-2023)
Table 7. Global Frovatriptan Revenue by Type (2018-2023) & ($ million)
Table 8. Global Frovatriptan Revenue Market Share by Type (2018-2023)
Table 9. Global Frovatriptan Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Frovatriptan Sales by Application (2018-2023) & (K Units)
Table 11. Global Frovatriptan Sales Market Share by Application (2018-2023)
Table 12. Global Frovatriptan Revenue by Application (2018-2023)
Table 13. Global Frovatriptan Revenue Market Share by Application (2018-2023)
Table 14. Global Frovatriptan Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Frovatriptan Sales by Company (2018-2023) & (K Units)
Table 16. Global Frovatriptan Sales Market Share by Company (2018-2023)
Table 17. Global Frovatriptan Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Frovatriptan Revenue Market Share by Company (2018-2023)
Table 19. Global Frovatriptan Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Frovatriptan Producing Area Distribution and Sales Area
Table 21. Players Frovatriptan Products Offered
Table 22. Frovatriptan Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Frovatriptan Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Frovatriptan Sales Market Share Geographic Region (2018-2023)
Table 27. Global Frovatriptan Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Frovatriptan Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Frovatriptan Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Frovatriptan Sales Market Share by Country/Region (2018-2023)
Table 31. Global Frovatriptan Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Frovatriptan Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Frovatriptan Sales by Country (2018-2023) & (K Units)
Table 34. Americas Frovatriptan Sales Market Share by Country (2018-2023)
Table 35. Americas Frovatriptan Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Frovatriptan Revenue Market Share by Country (2018-2023)
Table 37. Americas Frovatriptan Sales by Type (2018-2023) & (K Units)
Table 38. Americas Frovatriptan Sales by Application (2018-2023) & (K Units)
Table 39. APAC Frovatriptan Sales by Region (2018-2023) & (K Units)
Table 40. APAC Frovatriptan Sales Market Share by Region (2018-2023)
Table 41. APAC Frovatriptan Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Frovatriptan Revenue Market Share by Region (2018-2023)
Table 43. APAC Frovatriptan Sales by Type (2018-2023) & (K Units)
Table 44. APAC Frovatriptan Sales by Application (2018-2023) & (K Units)
Table 45. Europe Frovatriptan Sales by Country (2018-2023) & (K Units)
Table 46. Europe Frovatriptan Sales Market Share by Country (2018-2023)
Table 47. Europe Frovatriptan Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Frovatriptan Revenue Market Share by Country (2018-2023)
Table 49. Europe Frovatriptan Sales by Type (2018-2023) & (K Units)
Table 50. Europe Frovatriptan Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Frovatriptan Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Frovatriptan Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Frovatriptan Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Frovatriptan Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Frovatriptan Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Frovatriptan Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Frovatriptan
Table 58. Key Market Challenges & Risks of Frovatriptan
Table 59. Key Industry Trends of Frovatriptan
Table 60. Frovatriptan Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Frovatriptan Distributors List
Table 63. Frovatriptan Customer List
Table 64. Global Frovatriptan Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Frovatriptan Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Frovatriptan Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Frovatriptan Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Frovatriptan Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Frovatriptan Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Frovatriptan Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Frovatriptan Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Frovatriptan Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Frovatriptan Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Frovatriptan Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Frovatriptan Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Frovatriptan Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Frovatriptan Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Ligand Pharmaceuticals Basic Information, Frovatriptan Manufacturing Base, Sales Area and Its Competitors
Table 79. Ligand Pharmaceuticals Frovatriptan Product Portfolios and Specifications
Table 80. Ligand Pharmaceuticals Frovatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Ligand Pharmaceuticals Main Business
Table 82. Ligand Pharmaceuticals Latest Developments
Table 83. Endo Pharmaceuticals Basic Information, Frovatriptan Manufacturing Base, Sales Area and Its Competitors
Table 84. Endo Pharmaceuticals Frovatriptan Product Portfolios and Specifications
Table 85. Endo Pharmaceuticals Frovatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Endo Pharmaceuticals Main Business
Table 87. Endo Pharmaceuticals Latest Developments
Table 88. Doc Generici Basic Information, Frovatriptan Manufacturing Base, Sales Area and Its Competitors
Table 89. Doc Generici Frovatriptan Product Portfolios and Specifications
Table 90. Doc Generici Frovatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Doc Generici Main Business
Table 92. Doc Generici Latest Developments
Table 93. Menarini Basic Information, Frovatriptan Manufacturing Base, Sales Area and Its Competitors
Table 94. Menarini Frovatriptan Product Portfolios and Specifications
Table 95. Menarini Frovatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Menarini Main Business
Table 97. Menarini Latest Developments
Table 98. Novartis Basic Information, Frovatriptan Manufacturing Base, Sales Area and Its Competitors
Table 99. Novartis Frovatriptan Product Portfolios and Specifications
Table 100. Novartis Frovatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Novartis Main Business
Table 102. Novartis Latest Developments
Table 103. Almac Basic Information, Frovatriptan Manufacturing Base, Sales Area and Its Competitors
Table 104. Almac Frovatriptan Product Portfolios and Specifications
Table 105. Almac Frovatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Almac Main Business
Table 107. Almac Latest Developments
Table 108. Glenmark Generics Basic Information, Frovatriptan Manufacturing Base, Sales Area and Its Competitors
Table 109. Glenmark Generics Frovatriptan Product Portfolios and Specifications
Table 110. Glenmark Generics Frovatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Glenmark Generics Main Business
Table 112. Glenmark Generics Latest Developments
Table 113. Teva Basic Information, Frovatriptan Manufacturing Base, Sales Area and Its Competitors
Table 114. Teva Frovatriptan Product Portfolios and Specifications
Table 115. Teva Frovatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Teva Main Business
Table 117. Teva Latest Developments
Table 118. Zambon Basic Information, Frovatriptan Manufacturing Base, Sales Area and Its Competitors
Table 119. Zambon Frovatriptan Product Portfolios and Specifications
Table 120. Zambon Frovatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Zambon Main Business
Table 122. Zambon Latest Developments
Table 123. Apotex Basic Information, Frovatriptan Manufacturing Base, Sales Area and Its Competitors
Table 124. Apotex Frovatriptan Product Portfolios and Specifications
Table 125. Apotex Frovatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Apotex Main Business
Table 127. Apotex Latest Developments
Table 128. G.L. Pharma Basic Information, Frovatriptan Manufacturing Base, Sales Area and Its Competitors
Table 129. G.L. Pharma Frovatriptan Product Portfolios and Specifications
Table 130. G.L. Pharma Frovatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. G.L. Pharma Main Business
Table 132. G.L. Pharma Latest Developments
Table 133. Chanelle Pharma Basic Information, Frovatriptan Manufacturing Base, Sales Area and Its Competitors
Table 134. Chanelle Pharma Frovatriptan Product Portfolios and Specifications
Table 135. Chanelle Pharma Frovatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Chanelle Pharma Main Business
Table 137. Chanelle Pharma Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Frovatriptan
Figure 2. Frovatriptan Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Frovatriptan Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Frovatriptan Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Frovatriptan Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Hospital
Figure 10. Product Picture of Drug Store
Figure 11. Global Frovatriptan Sales Market Share by Type in 2022
Figure 12. Global Frovatriptan Revenue Market Share by Type (2018-2023)
Figure 13. Frovatriptan Consumed in Menstrual Migraines
Figure 14. Global Frovatriptan Market: Menstrual Migraines (2018-2023) & (K Units)
Figure 15. Frovatriptan Consumed in Migraine with Aura
Figure 16. Global Frovatriptan Market: Migraine with Aura (2018-2023) & (K Units)
Figure 17. Frovatriptan Consumed in Migraine without Aura
Figure 18. Global Frovatriptan Market: Migraine without Aura (2018-2023) & (K Units)
Figure 19. Global Frovatriptan Sales Market Share by Application (2022)
Figure 20. Global Frovatriptan Revenue Market Share by Application in 2022
Figure 21. Frovatriptan Sales Market by Company in 2022 (K Units)
Figure 22. Global Frovatriptan Sales Market Share by Company in 2022
Figure 23. Frovatriptan Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Frovatriptan Revenue Market Share by Company in 2022
Figure 25. Global Frovatriptan Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Frovatriptan Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Frovatriptan Sales 2018-2023 (K Units)
Figure 28. Americas Frovatriptan Revenue 2018-2023 ($ Millions)
Figure 29. APAC Frovatriptan Sales 2018-2023 (K Units)
Figure 30. APAC Frovatriptan Revenue 2018-2023 ($ Millions)
Figure 31. Europe Frovatriptan Sales 2018-2023 (K Units)
Figure 32. Europe Frovatriptan Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Frovatriptan Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Frovatriptan Revenue 2018-2023 ($ Millions)
Figure 35. Americas Frovatriptan Sales Market Share by Country in 2022
Figure 36. Americas Frovatriptan Revenue Market Share by Country in 2022
Figure 37. Americas Frovatriptan Sales Market Share by Type (2018-2023)
Figure 38. Americas Frovatriptan Sales Market Share by Application (2018-2023)
Figure 39. United States Frovatriptan Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Frovatriptan Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Frovatriptan Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Frovatriptan Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Frovatriptan Sales Market Share by Region in 2022
Figure 44. APAC Frovatriptan Revenue Market Share by Regions in 2022
Figure 45. APAC Frovatriptan Sales Market Share by Type (2018-2023)
Figure 46. APAC Frovatriptan Sales Market Share by Application (2018-2023)
Figure 47. China Frovatriptan Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Frovatriptan Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Frovatriptan Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Frovatriptan Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Frovatriptan Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Frovatriptan Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Frovatriptan Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Frovatriptan Sales Market Share by Country in 2022
Figure 55. Europe Frovatriptan Revenue Market Share by Country in 2022
Figure 56. Europe Frovatriptan Sales Market Share by Type (2018-2023)
Figure 57. Europe Frovatriptan Sales Market Share by Application (2018-2023)
Figure 58. Germany Frovatriptan Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Frovatriptan Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Frovatriptan Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Frovatriptan Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Frovatriptan Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Frovatriptan Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Frovatriptan Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Frovatriptan Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Frovatriptan Sales Market Share by Application (2018-2023)
Figure 67. Egypt Frovatriptan Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Frovatriptan Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Frovatriptan Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Frovatriptan Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Frovatriptan Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Frovatriptan in 2022
Figure 73. Manufacturing Process Analysis of Frovatriptan
Figure 74. Industry Chain Structure of Frovatriptan
Figure 75. Channels of Distribution
Figure 76. Global Frovatriptan Sales Market Forecast by Region (2024-2029)
Figure 77. Global Frovatriptan Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Frovatriptan Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Frovatriptan Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Frovatriptan Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Frovatriptan Revenue Market Share Forecast by Application (2024-2029)